Cardiovascular Effects of Second-hand Smoke Help Explain the Benefits of Smoke-free Legislation on Heart Disease Burden

Journal of Cardiovascular Nursing

Volumn 21, Issue 6, 2006, Pages 457-462

  Barnoya, Joaquin ^a   Glantz, Stanton A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cardiovascular diseases; Tobacco; Tobacco smoke pollution

Indexed keywords

CARDIOVASCULAR SYSTEM; DRUG EFFECT; HEART DISEASE; HUMAN; INDOOR AIR POLLUTION; LEGAL ASPECT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SMOKING; UNITED STATES;

CARDIOVASCULAR SYSTEM; HEART DISEASES; HUMANS; OXIDATIVE STRESS; SMOKING; TOBACCO SMOKE POLLUTION; UNITED STATES;

EID: 33846960758     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200611000-00008     Document Type: Article

References (61)

1. California Environmental Protection Agency. Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Part B:; Health Effects. California: Office of Environmental Health Hazard Assessment; June 24, 2005.
2. Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111(20):2684-2698.
3. Whincup PH, Gilg JA, Emberson JR, et al. Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ. 2004;329(7459):200-205.
4. Fichtenberg CM, Glantz SA. Association of the California Tobacco Control Program with declines in cigarette consumption and mortality from heart disease. N Engl J Med. 2000;343(24):1772-1777.
5. Fichtenberg CM, Glantz SA. Effect of smoke free workplaces on smoking behaviour: systematic review. BMJ. 2002;325(7357):188.
6. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731-1737.
7. Burghuber OC, Punzengruber C, Sinzinger H, Haber P, Silberbauer K. Platelet sensitivity to prostacyclin in smokers and non-smokers. Chest. 1986;90(1):34-38.
8. Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation. 2004;109(1):78-83.
9. Schmid P, Karanikas G, Kritz H, et al. Passive smoking and platelet thromboxane. Thromb Res. 1996;81(4):451-460.
10. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42(7):1149-1160.
11. Puranik R, Celermajer DS. Smoking and endothelial function. Prog Cardiovasc Dis. 2003;45(6):443-458.
12. Otsuka R, Watanabe H, Hirata K, et al. Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA. 2001;286:436-441.
13. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334(3):150-154.
14. Hutchison SJ, Sudhir K, Chou TM, et al. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol. 1997;29(4):800-807.
15. Hutchison SJ, Glantz SA, Zhu B-Q, et al. In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J Am Coll Cardiol. 1998;32(5):1463-1467.
16. Barua RS, Ambrose JA, Eales-Reynolds LJ, DeVoe MC, Zervas JG, Saha DC. Dysfunctional endothelial nitric oxide biosynthesis in healthy smokers with impaired endothelium-dependent vasodilatation. Circulation. 2001;104(16):1905-1910.
17. Hutchison SJ, Sudhir K, Sievers RE, et al. Effects of L-arginine on atherogenesis and endothelial dysfunction due to secondhand smoke. Hypertension. 1999;34(1):44-50.
18. Hutchinson S, Ibarra M, Chou T, et al. L-Arginine restores normal endothelium-medicated relaxation in hypercholesterolemic rabbits exposed to environmental tobacco smoke (abstract). J Am Coll Cardiol. 1996;27(2 suppl):39A.
19. Wells AJ. Passive smoking as a cause of heart disease. J Am Coll Cardiol. 1994;24(2):546-554.
20. Mullick AE, McDonald JM, Melkonian G, Talbot P, Pinkerton KE, Rutledge JC. Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. Am J Physiol Heart Circ Physiol. 2002;283(2):H591-H597.
21. Bernhard D, Pfister G, Huck CW, et al. Disruption of vascular endothelial homeostasis by tobacco smoke-impact on atherosclerosis. FASEB J. 2003;17:2302-2304.
22. Cucina A, Sapienza P, Borrelli V, et al. Nicotine reorganizes cytoskeleton of vascular endothelial cell through platelet-derived growth BB factor. J Surg Res. 2000;92(2):233-238.
23. Raitakari OT, Adams MR, McCredie RJ, Griffiths KA, Celermajer DS. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med. 1999;130(7):578-581.
24. Schwarzacher SP, Hutchison S, Chou TM, et al. Antioxidant diet preserves endothelium-dependent vasodilatation in resistance arteries of hypercholesterolemic rabbits exposed to environmental tobacco smoke. J Cardiovasc Pharmacol. 1998;31(5):649-653.
25. Stefanadis C, Tsiamis E, Vlachopoulos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation. 1997;95(1):31-38.
26. Stefanadis C, Vlachopoulos C, Tsiamis E, et al. Unfavorable effects of passive smoking on aortic function in men. Ann Intern Med. 1998;128(6):426-434.
27. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135-1143.
28. Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Effect of exposure to secondhand smoke on markers of inflammation: the ATTICA study. Am J Med. 2004;116(3):145-150.
29. Mizoue T, Ueda R, Hino Y, Yoshimura T. Workplace exposure to environmental tobacco smoke and high density lipoprotein cholesterol among nonsmokers. Am J Epidemiol. 1999;150(10):1068-1072.
30. Moffatt RJ, Chelland SA, Pecott DL, Stamford BA. Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C. Prev Med. 2004;38(5):637-641.
31. Moskowitz WB, Schwartz PF, Schieken RM. Childhood passive smoking, race, and coronary artery disease risk: the MCV Twin Study. Medical College of Virginia. Arch Pediatr Adolesc Med. 1999;153(5):446-453.
32. Neufeld EJ, Mietus-Snyder M, Beiser AS, Baker AL, Newburger JW. Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profiles. Circulation. 1997;96(5):1403-1407.
33. Yang Z, Knight CA, Mamerow MM, et al. Prenatal environmental tobacco smoke exposure promotes adult atherogenesis and mitochondrial damage in apolipoprotein E−/− mice fed a chow diet. Circulation. 2004;110(24):3715-3720.
34. Tani S, Dimayuga PC, Anazawa T, et al. Aberrant antibody responses to oxidized LDL and increased intimal thickening in apoE−/− mice exposed to cigarette smoke. Atherosclerosis. 2004;175(1):7-14.
35. Howard G, Wagenknecht LE, Burke GL, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279(2):119-124.
36. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003;108(16):1912-1916.
37. Valkonen M, Kuusi T. Passive smoking induces atherogenic changes in low-density lipoprotein. Circulation. 1998;97(20):2012-2016.
38. Penn A, Snyder CA. Inhalation of sidestream cigarette smoke accelerates development of arteriosclerotic plaques. Circulation. 1993;88(4 pt 1):1820-1825.
39. Zhu BQ, Sun YP, Sievers RE, Isenberg WM, Glantz SA, Parmley WW. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993;21(1):225-232.
40. Knight-Lozano CA, Young CG, Burow DL, et al. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation. 2002;105(7):849-854.
41. Sun YP, Zhu BQ, Browne AE, et al. Nicotine does not influence arterial lipid deposits in rabbits exposed to second-hand smoke. Circulation. 2001;104(7):810-814.
42. Galis ZS, Khatri JJ. Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, The Bad, and The Ugly. Circ Res. 2002;90(3):251-262.
43. Kuo WW, Wu CH, Lee SD, et al. Second-hand smoke-induced cardiac fibrosis is related to the Fas death receptor apoptotic pathway without mitochondria-dependent pathway involvement in rats. Environ Health Perspect. 2005;113(10):1349-1353.
44. Carty CS, Soloway PD, Kayastha S, et al. Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells. J Vasc Surg. 1996;24(6):927-934. discussion 934-925.
45. Perlstein TS, Lee RT. Smoking, metalloproteinases, and vascular disease. Arterioscler Thromb Vasc Biol. 2006;26(2):250-256.
46. Zhu BQ, Sun YP, Sievers RE, Glantz SA, Parmley WW, Wolfe CL. Exposure to environmental tobacco smoke increases myocardial infarct size in rats. Circulation. 1994;89(3):1282-1290.
47. Zhu BQ, Sun YP, Sudhir K, et al. Effects of second-hand smoke and gender on infarct size of young rats exposed in utero and in the neonatal to adolescent period. J Am Coll Cardiol. 1997;30(7):1878-1885.
48. Torok J, Gvozdjakova A, Kucharska J, et al. Passive smoking impairs endothelium-dependent relaxation of isolated rabbit arteries. Physiol Res. 2000;49(1):135-141.
49. Ahmadzadehfar H, Oguogho A, Efthimiou Y, Kritz H, Sinzinger H. Passive cigarette smoking increases isoprostane formation. Life Sci. 2006;78(8):894-897.
50. Howard DJ, Ota RB, Briggs LA, Hampton M, Pritsos CA. Environmental tobacco smoke in the workplace induces oxidative stress in employees, including increased production of 8-hydroxy-2′-deoxyguanosine. Cancer Epidemiol Biomarkers Prev. 1998;7(2):141-146.
51. Shekelle P, Morton SC, Jungvig LK, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004;19(4):380-389.
52. Gvozdjakova A, Simko F, Kucharska J, Braunova Z, Psenek P, Kyselovic J. Captopril increased mitochondrial coenzyme Q(10) level, improved respiratory chain function and energy production in the left ventricle in rabbits with smoke mitochondrial cardiomyopathy. Biofactors. 1999;10(1):61-65.
53. Gvozdjakova A, Kucharska J, Gvozdjak J. Effect of smoking on the oxidative processes of cardiomyocytes. Cardiology. 81;1992:81-84.
54. Pope CA 3rd, Eatough DJ, Gold DR, et al. Acute exposure to environmental tobacco smoke and heart rate variability. Environ Health Perspect. 2001;109(7):711-716.
55. Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004;109(21):2655-2671.
56. Kendall DM, Sobel BE, Coulston AM, et al. The insulin resistance syndrome and coronary artery disease. Coron Artery Dis. 2003;14(4):335-348.
57. Henkin L, Zaccaro D, Haffner S, et al. Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Ann Epidemiol. 1999;9(5):290-296.
58. Weitzman M, Cook S, Auinger P, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation. 2005;112(6):862-869.
59. Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ. 2004;328(7446):977-980.
60. Bartecchi C, Alsever R, Nevin-Woods C, Estacio R, Krantz M. A citywide smoking ordinance reduces the incidence of acute myocardial infarction. Presented at: 2005 Meeting of the American Heart Association; Dallas, Tex.
61. Ong MK, Glantz SA. Cardiovascular health and economic effects of smoke-free workplaces. Am J Med. 2004;117(1):32-38.